Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Shares Issued (2016 - 2025)

Arrowhead Pharmaceuticals' Shares Issued history spans 15 years, with the latest figure at $46.8 million for Q4 2025.

For Q4 2025, Shares Issued changed N/A year-over-year to $46.8 million; the TTM value through Dec 2025 reached $71.8 million, up 3285.11%, while the annual FY2025 figure was $25.0 million, 946.46% up from the prior year.
Shares Issued reached $46.8 million in Q4 2025 per ARWR's latest filing, up from $21.7 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $429.0 million in Q1 2024 to a low of -$429.3 million in Q2 2024.
Average Shares Issued over 5 years is $5.2 million, with a median of $1.1 million recorded in 2023.
The largest YoY upside for Shares Issued was 82399.62% in 2024 against a maximum downside of 37887.41% in 2024.
A 5-year view of Shares Issued shows it stood at $11.3 million in 2021, then plummeted by 94.9% to $576000.0 in 2022, then plummeted by 53.65% to $267000.0 in 2023, then skyrocketed by 794.76% to $2.4 million in 2024, then soared by 1860.32% to $46.8 million in 2025.
Per Business Quant, the three most recent readings for ARWR's Shares Issued are $46.8 million (Q4 2025), $21.7 million (Q2 2025), and $3.3 million (Q1 2025).